Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson N Stone

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
The Journal of Urology|April 5, 2014
15-year cause specific and all-cause survival following brachytherapy for prostate cancer: negative impact of long-term hormonal therapyNelson N Stone, Richard G Stock
The Journal of Urology|December 14, 2004
Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapySteven Lehrer, Nelson N Stone, Richard G Stock
The Journal of Urology|February 16, 2005
Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancerNelson N Stone, Richard G Stock, Pam Unger
Brachytherapy|March 29, 2020
Long-term biochemical control and cause-specific survival in men with Gleason grade Group 4 and 5 prostate cancer treated with brachytherapy and external beam irradiationNelson N Stone, Vassilios Skouteris, Richard G Stock
Brachytherapy|November 7, 2019
Transperineal mapping biopsy improves selection of brachytherapy boost for men with localized prostate cancerNelson N Stone, Vassilios Skouteris, Panagiotis-Marios Metsinis
Mayo Clinic Proceedings|July 13, 2004
Morbidity after brachytherapy for prostate adenocarcinomaThomas M Pisansky, Brian J Davis, Nelson N Stone
International Journal of Radiation Oncology, Biology, Physics|October 12, 2011
PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failureEric C Ko, Nelson N Stone, Richard G Stock
Brachytherapy|February 7, 2012
Biopsy and implantation of the seminal vesiclesNelson N Stone, Vassilios M Skouteris, Richard G Stock
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Urinary symptom flare following I-125 prostate brachytherapyJamie A Cesaretti, Nelson N Stone, Richard G Stock
International Journal of Radiation Oncology, Biology, Physics|March 2, 2002
Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantationLucille N Lee, Richard G Stock, Nelson N Stone
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
The Journal of Urology|April 5, 2014
15-year cause specific and all-cause survival following brachytherapy for prostate cancer: negative impact of long-term hormonal therapyNelson N Stone, Richard G Stock
The Journal of Urology|December 14, 2004
Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapySteven Lehrer, Nelson N Stone, Richard G Stock
The Journal of Urology|February 16, 2005
Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancerNelson N Stone, Richard G Stock, Pam Unger
Brachytherapy|March 29, 2020
Long-term biochemical control and cause-specific survival in men with Gleason grade Group 4 and 5 prostate cancer treated with brachytherapy and external beam irradiationNelson N Stone, Vassilios Skouteris, Richard G Stock
Brachytherapy|November 7, 2019
Transperineal mapping biopsy improves selection of brachytherapy boost for men with localized prostate cancerNelson N Stone, Vassilios Skouteris, Panagiotis-Marios Metsinis
Mayo Clinic Proceedings|July 13, 2004
Morbidity after brachytherapy for prostate adenocarcinomaThomas M Pisansky, Brian J Davis, Nelson N Stone
International Journal of Radiation Oncology, Biology, Physics|October 12, 2011
PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failureEric C Ko, Nelson N Stone, Richard G Stock
Brachytherapy|February 7, 2012
Biopsy and implantation of the seminal vesiclesNelson N Stone, Vassilios M Skouteris, Richard G Stock
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Urinary symptom flare following I-125 prostate brachytherapyJamie A Cesaretti, Nelson N Stone, Richard G Stock
International Journal of Radiation Oncology, Biology, Physics|March 2, 2002
Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantationLucille N Lee, Richard G Stock, Nelson N Stone
Pageof 12